Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Cost of Revenue (2020 - 2024)

LifeStance Health (LFST) has disclosed Cost of Revenue for 5 consecutive years, with $212.3 million as the latest value for Q3 2024.

  • On a quarterly basis, Cost of Revenue rose 13.72% to $212.3 million in Q3 2024 year-over-year; TTM through Sep 2024 was $829.8 million, a 14.78% increase, with the full-year FY2023 number at $753.6 million, up 21.05% from a year prior.
  • Cost of Revenue was $212.3 million for Q3 2024 at LifeStance Health, down from $214.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $214.5 million in Q2 2024 to a low of $31.3 million in Q2 2020.
  • A 5-year average of $153.3 million and a median of $162.0 million in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: surged 249.61% in 2021, then rose 12.42% in 2024.
  • LifeStance Health's Cost of Revenue stood at $68.8 million in 2020, then surged by 97.17% to $135.7 million in 2021, then rose by 22.78% to $166.7 million in 2022, then grew by 18.37% to $197.3 million in 2023, then grew by 7.6% to $212.3 million in 2024.
  • Per Business Quant, the three most recent readings for LFST's Cost of Revenue are $212.3 million (Q3 2024), $214.5 million (Q2 2024), and $205.7 million (Q1 2024).